- Home
- AZI vs MRSN Comparison
AZI vs MRSN Comparison
Compare AZI & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZI
- MRSN
- Stock Information
- Founded
- AZI 2010
- MRSN 2001
- Country
- AZI China
- MRSN United States
- Employees
- AZI N/A
- MRSN N/A
- Industry
- AZI
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- AZI
- MRSN Health Care
- Exchange
- AZI Nasdaq
- MRSN Nasdaq
- Market Cap
- AZI 84.9M
- MRSN 71.9M
- IPO Year
- AZI 2024
- MRSN 2017
- Fundamental
- Price
- AZI $1.00
- MRSN $0.34
- Analyst Decision
- AZI
- MRSN Buy
- Analyst Count
- AZI 0
- MRSN 3
- Target Price
- AZI N/A
- MRSN $4.00
- AVG Volume (30 Days)
- AZI 186.1K
- MRSN 3.0M
- Earning Date
- AZI 01-27-2025
- MRSN 03-03-2025
- Dividend Yield
- AZI N/A
- MRSN N/A
- EPS Growth
- AZI N/A
- MRSN N/A
- EPS
- AZI N/A
- MRSN N/A
- Revenue
- AZI $124,737,000.00
- MRSN $40,497,000.00
- Revenue This Year
- AZI N/A
- MRSN N/A
- Revenue Next Year
- AZI N/A
- MRSN N/A
- P/E Ratio
- AZI N/A
- MRSN N/A
- Revenue Growth
- AZI 9.86
- MRSN 9.88
- 52 Week Low
- AZI $0.45
- MRSN $0.32
- 52 Week High
- AZI $4.05
- MRSN $4.64
- Technical
- Relative Strength Index (RSI)
- AZI N/A
- MRSN 29.53
- Support Level
- AZI N/A
- MRSN $0.41
- Resistance Level
- AZI N/A
- MRSN $0.42
- Average True Range (ATR)
- AZI 0.00
- MRSN 0.04
- MACD
- AZI 0.00
- MRSN -0.00
- Stochastic Oscillator
- AZI 0.00
- MRSN 11.85
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd is one of China's leading and fast-growing lifecycle automotive service providers. It provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels nationwide. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.